British International Investment controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2021
Civil-society opposition to the BII rebrand
NGOs and trade unions argued that the rebrand risked placing private-sector investment, profit-making, and geopolitical competition ahead of poverty reduction and other development objectives.
2010
Criticism of CDC's commercial orientation and Actis spin-out
Private Eye and some British politicians criticised CDC's perceived shift away from development benefits toward profit generation and questioned the valuation and benefits of the 2004 Actis transaction. The criticism contributed to parliamentary scrutiny and a government review.